75 related articles for article (PubMed ID: 8243209)
1. Preferential loss of abnormal prostate carcinoma cells by collagenase treatment.
König JJ; van Dongen JW; Schröder FH
Cytometry; 1993 Oct; 14(7):805-10. PubMed ID: 8243209
[TBL] [Abstract][Full Text] [Related]
2. Variations in DNA aneuploid cell content during tumor dissociation in human colon and head and neck cancers analyzed by flow cytometry.
Ensley JF; Maciorowski Z; Hassan M; Pietraszkiewicz H; Sakr W; Heilbrun LK
Cytometry; 1993; 14(5):550-8. PubMed ID: 8354128
[TBL] [Abstract][Full Text] [Related]
3. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric DNA analysis of colon adenocarcinomas: a comparative study of preparatory techniques.
Crissman JD; Zarbo RJ; Niebylski CD; Corbett T; Weaver D
Mod Pathol; 1988 May; 1(3):198-204. PubMed ID: 2467284
[TBL] [Abstract][Full Text] [Related]
6. Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry.
Berner A; Danielsen HE; Juul NO; Juul ME; Pettersen EO; Reith A; Nesland JM; Fosså SD
Anal Cell Pathol; 1993 Nov; 5(6):339-52. PubMed ID: 8305330
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S
Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974
[TBL] [Abstract][Full Text] [Related]
8. Comparison of tissue disaggregation techniques of transitional cell bladder carcinomas for flow cytometry and chromosomal analysis.
Smeets AW; Pauwels RP; Beck HL; Feitz WF; Geraedts JP; Debruyne FM; Laarakkers L; Vooijs GP; Ramaekers FC
Cytometry; 1987 Jan; 8(1):14-9. PubMed ID: 3026756
[TBL] [Abstract][Full Text] [Related]
9. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
Claflin AJ; Pollack A; Malinin T; Block NL; Irvin GL
J Natl Cancer Inst; 1982 Jul; 69(1):79-87. PubMed ID: 6954325
[TBL] [Abstract][Full Text] [Related]
11. Tissue culture loss of aneuploid cells from carcinomas of the prostate.
König JJ; Teubel W; van Dongen JW; Hagemeijer A; Romijn JC; Schröder FH
Genes Chromosomes Cancer; 1993 Sep; 8(1):22-7. PubMed ID: 7691155
[TBL] [Abstract][Full Text] [Related]
12. Selection toward diploid cells in prostatic carcinoma derived cell cultures.
Ketter R; Zwergel T; Romanakis K; Unteregger G; Ziegler M; Zang KD; Wullich B
Prostate; 1996 Jun; 28(6):364-71. PubMed ID: 8650073
[TBL] [Abstract][Full Text] [Related]
13. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cytogenetics, interphase cytogenetics, and DNA flow cytometry in bone tumors.
Tarkkanen M; Nordling S; Böhling T; Kivioja A; Karaharju E Szymanska J; Elomaa I; Knuutila S
Cytometry; 1996 Sep; 26(3):185-91. PubMed ID: 8889389
[TBL] [Abstract][Full Text] [Related]
15. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
16. Tissue disaggregation for flow cytometric DNA analysis: comparison of fine-needle aspiration and an automated mechanical procedure.
Ottesen GL; Christensen IJ; Larsen JK; Hansen B; Andersen JA
Cytometry; 1996 Mar; 26(1):65-8. PubMed ID: 8809483
[TBL] [Abstract][Full Text] [Related]
17. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric determination of ploidy in prostatic adenocarcinoma and its relation to clinical outcome.
Blatstein LM; Ginsberg PC; Daskal I; Finkelstein LH
J Am Osteopath Assoc; 1993 Apr; 93(4):463-8, 471-2. PubMed ID: 8478220
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin labeling of breast cancer cells extracted from paraffin-embedded tissue for bivariate flow cytometric analysis.
Glogovac JK; Porter PL; Banker DE; Rabinovitch PS
Cytometry; 1996 Jul; 24(3):260-7. PubMed ID: 8800559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
